Fetal Retinoid Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Fetal Retinoid Syndrome

What is the definition of Fetal Retinoid Syndrome?
Fetal retinoid syndrome is a characteristic pattern of physical birth defects in a baby that has been exposed to retinoids during pregnancy. The best-known retinoid is isotretinoin (Accutane), a drug used to treat severe cystic acne. Babies exposed to retinoids during pregnancy may have a wide variety of symptoms. Some may have no symptoms at all, others may have only intellectual and learning problems, while others will have very severe symptoms. Birth defects associated with retinoid exposure include: • Growth delay • Excess fluid around the brain (hydrocephalus) • Abnormally small head size (microcephaly) • Intellectual and learning disabilities • Ear and eye abnormalities • A split in the roof of the mouth (cleft palate) and other facial differences • Heart defects. It is thought that 20-35% of fetuses exposed to retinoids during pregnancy will develop some of these birth defects. Retinoids can cause these birth defects in the early weeks of pregnancy, even before a woman knows that she is pregnant. Some of the birth defects associated with Fetal retinoid syndrome may be diagnosed by ultrasound during pregnancy. Currently, public health programs exist to help reduce the chance that a woman will use retinoids if she is considering getting pregnant.
What are the alternative names for Fetal Retinoid Syndrome?
  • Fetal retinoid syndrome
  • Accutane fetal effects of
  • Accutane-exposed pregnancies
  • Acutane embryopathy
  • Isotretinoin (RoAccutane) embryopathy
  • Isotretinoin embryopathy
  • Isotretinoin fetal effects of
  • Isotretinoin teratogen syndrome
Who are the top Fetal Retinoid Syndrome Local Doctors?
Elite in Fetal Retinoid Syndrome
Elite in Fetal Retinoid Syndrome
Referral may be required
Jerusalem, JM, IL 

Abraham Fainsod practices practicing medicine in Jerusalem, Israel. Mr. Fainsod is rated as an Elite expert by MediFind in the treatment of Fetal Retinoid Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Fetal Retinoid Syndrome, Fetal Alcohol Syndrome (FAS), Campomelic Dysplasia, and Campomelia Cumming Type.

Distinguished in Fetal Retinoid Syndrome
Distinguished in Fetal Retinoid Syndrome
Referral required

Office

1625 Straits Tpke Ste 306, 
Middlebury, CT 
Languages Spoken:
English

Christopher Bunick is a Dermatologist practicing medicine in Middlebury, Connecticut. Dr. Bunick is rated as a Distinguished provider by MediFind in the treatment of Fetal Retinoid Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Lamellar Ichthyosis, Nonbullous Congenital Ichthyosiform Erythroderma, Acne, and Atopic Dermatitis.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Fetal Retinoid Syndrome
Pediatrics
Distinguished in Fetal Retinoid Syndrome
Pediatrics
Referral may be required

Lucille Packard Children's Hospital 030962

770 Welch Rd, 
Palo Alto, CA 
Languages Spoken:
English
Offers Telehealth

Joyce Teng is a Pediatrics provider practicing medicine in Palo Alto, California. Dr. Teng is rated as a Distinguished provider by MediFind in the treatment of Fetal Retinoid Syndrome. She is also highly rated in 136 other conditions, according to our data. Her clinical expertise encompasses Dowling-Meara Epidermolysis Bullosa Simplex, Dominant Dystrophic Epidermolysis Bullosa, Nevoid Basal Cell Carcinoma Syndrome, Fetal Retinoid Syndrome, and Liver Embolization.

What are the latest Fetal Retinoid Syndrome Clinical Trials?
The Impact of COVID-19 on Maternal and Neonatal Outcomes

Summary: The novel coronavirus (SARS-CoV-2) infection (COVID-19) has caused a worldwide pandemic. There is still much that is unknown regarding the virus, especially its effects on pregnancy, the fetus, and the neonate. This study seeks to evaluate adverse pregnancy and neonatal outcomes related to COVID-19 infection. The FDA has authorized emergency use authorization for the SARS-CoV-2 messenger ribonucle...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Cancer of the Pancreas Screening-5 CAPS5)Study

Summary: Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center